1MANUSCRIPT PREPARATION524-5242A novel technique using hydrophilic polymers to promote axonal fusionRavinder Bamba, D Colton Riley, Nathaniel D Kelm, Mark D Does, Richard D Dortch, Wesley P hTayer525-5283Examining the properties and therapeutic potential of glial restricted precursors in spinal cord injuryKazuo Hayakawa, Christopher Haas, Itzhak Fischer529-5334The choroid plexus-cerebrospinal lfuid interface in Alzheimer’s disease：more than just a barrierSriram Balusu, Marjana Brkic, Claude Libert, Roosmarijn E Vandenbroucke534-5375Physical interactions between activated microglia and injured axons:do all contacts lead to phagocytosis?Audrey D. Lafrenaye538-5406Repositioning again of zonisamide for nerve regeneration541-5427Local translation of cell adhesion molecules in axonsShruti Jain, Kristy Welshhans543-5448Counteraction of Nogo-A and axonal growth inhibitors by green tea polyphenols and other natural productsTiffany K. Fan, Usha Gundimeda, William J. Mack, Rayudu Gopalakrishna545-5469Analysis of lfuoxetine-induced plasticity mechanisms as a strategy for understanding plasticity related neural disordersFrancesco Mattia Rossi547-54810Role of pleiotrophin-protein tyrosine phosphatase receptor type Z signaling in myelination549-55111Toll-like receptor-4 antagonism mediates beneifts during neuroinlfammationSagar Gaikwad, Challagundla Naveen, Reena Agrawal-Rajput552-55312Immunomodulatory approaches to CNS injury：extracellular matrix and exosomes from extracellular matrix conditioned macrophagesYolandi van der Merwe, Michael B. Steketee554-55613Laser therapy on points of acupuncture on nerve repairRenata F. de Oliveira, Patrícia M. de Freitas557-55814Prevention and protection against cerebral ischemic injury using acupuncturePhilip V. Peplow, Bridget Martinez559-56015Exploring a need for improved preclinical models of post-stroke depressionNitish Mittal, Patricia D. Hurn, Timothy Schallert561-56216Multi-watt near-infrared light therapy as a neuroregenerative treatment for traumatic brain injuryhTeodore A. Henderson563-56517Neuroprotective effect of antioxidant compoundsRachid Skouta566-56718Autologous bone marrow mononuclear cells as neuroprotective treatment of amyotrophic lateral sclerosisFrancisco José Ruiz-López, Miguel Blanquer568-56919Paracrine factors for neurodegenerative disorders：special emphasis on Parkinson’s diseaseStefano Di Santo, Hans Rudolf Widmer570-57120Extrinsic and intrinsic mechanisms of axon regeneration：the need for spinal cord injury treatment strategies to address bothChristina Francisca Vogelaar572-574 